Hain Celestial ‘Natural’ Case Could Set Precedent Favorable To Industry
This article was originally published in The Rose Sheet
Hain Celestial is not out of the woods regarding the truthfulness of its JASON natural claims, with a California appellate court reversing a lower court’s 2012 dismissal of a false-advertising class action against the firm. However, the appeals court agrees that FDA should have primary jurisdiction over natural cosmetics claims, which could result in the Hain case being stayed until the agency gets around to defining “natural” as it applies to cosmetics.
You may also be interested in...
Mayer Brown attorney Dale Giali discusses the "natural" litigation landscape, where litigants increasingly are sparring over the appropriateness of stays in light of FDA's comment-gathering initiative launched in 2015.
Plaintiffs against Florida-based Green Roads used certificates of analysis the company makes freely available to consumers to determine that batches of two of the company’s products contained “significantly” less cannabidiol versus labeled amounts. A Florida federal court rejected the firm’s motion to dismiss, but it is interested in seeing how FDA rulemaking develops.